11/25/2020  9:54:09 AM Chg. +0.300 Volume Bid10:03:34 AM Ask10:03:34 AM Market Capitalization Dividend Y. P/E Ratio
122.150EUR +0.25% 365
Turnover: 44,251.150
122.000Bid Size: 300 122.100Ask Size: 300 23.75 bill.EUR - -

Business description

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Coloplast's business includes ostomy care, urology and continence care, and wound and skin care.
 

Management board & Supervisory board

CEO
Kristian Villumsen
Management board
Anders Lonning-Skovgaard, Allan Rasmussen, Camilla G. Møhl, Nicolai Buhl Andersen, Paul Marcun
Supervisory board
Lars Rasmussen, Birgitte Nielsen, Carsten Hellmann, Jette Nygaard-Andersen, Jørgen Tang-Jensen, Niels Peter Louis-Hansen, Nikolaj Kyhe Gundersen, Roland Vendelbo Pedersen, Thomas Barfod
 

Company data

Name: Coloplast Group
Address: Holtedam 1-3,DK-3050 Humlebaek
Phone: +45-4911-1111
Fax: -
E-mail: coloplast@colopolast.com
Internet: www.coloplast.com/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 9/30
Free Float: 64.20%
IPO date: -

Investor relations

Name: Ellen Bjurgert
IR phone: +45-4911-3376
IR Fax: +45-4911-1555
IR e-mail: dkebj@coloplast.com

Company calendar

CW 45 | 11/1/2021 4th Quarter/Annual Report
CW 49 | 12/2/2021 General Shareholder Meeting
CW 50 | 12/7/2021 Dividend Payment
 

Main Shareholders

Freefloat
 
64.20%
Niels Peter Louis-Hansen
 
20.70%
Aage og Johanne Louis-Hanses Fond
 
11.40%
Benedicte Find
 
3.70%